StockData
Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc. (XTNT) stock

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3075% below fair value
$0.28−0.00 (-0.94%)

Close on Nov 12, 2026Market cap $38.62MP/E –Yield –

Xtant Medical gross margin

Gross margin is gross profit as a percentage of revenue.

Xtant Medical's gross margin for the twelve months ending Jun 30, 2026 was 59.4%. For fiscal 2025 it was 62.9%, against 58.2% the year before. The highest annual figure on record is 78.2% in fiscal 2010.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202562.9%+4.8
FY2024Dec 31, 202458.2%−2.6
FY2023Dec 31, 202360.8%+5.3
FY2022Dec 31, 202255.4%−3.4
FY2021Dec 31, 202158.8%−5.7
FY2020Dec 31, 202064.5%−1.3
FY2019Dec 31, 201965.7%+5.5
FY2018Dec 31, 201860.2%−0.4
FY2017Dec 31, 201760.6%−8.6
FY2016Dec 31, 201669.2%+3.4
FY2015Dec 31, 201565.9%+2.7
FY2014Dec 31, 201463.1%+6.0
FY2013Dec 31, 201357.1%−11.5
FY2012Dec 31, 201268.7%−1.1
FY2011Dec 31, 201169.8%−8.4
FY2010Dec 31, 201078.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202657.9%−10.7
Q1 FY2026Mar 31, 202657.3%−4.2
Q4 FY2025Dec 31, 202554.9%+4.0
Q3 FY2025Sep 30, 202566.1%+7.8
Q2 FY2025Jun 30, 202568.6%+6.5
Q1 FY2025Mar 31, 202561.5%−0.6
Q4 FY2024Dec 31, 202450.8%−10.1
Q3 FY2024Sep 30, 202458.4%−2.9
Q2 FY2024Jun 30, 202462.1%+0.5
Q1 FY2024Mar 31, 202462.1%+3.4
Q4 FY2023Dec 31, 202361.0%+6.6
Q3 FY2023Sep 30, 202361.3%+6.7
Q2 FY2023Jun 30, 202361.6%+6.8
Q1 FY2023Mar 31, 202358.7%+0.4
Q4 FY2022Dec 31, 202254.4%−0.7
Q3 FY2022Sep 30, 202254.6%+2.4
Q2 FY2022Jun 30, 202254.8%−8.7
Q1 FY2022Mar 31, 202258.3%−6.2
Q4 FY2021Dec 31, 202155.1%−9.0
Q3 FY2021Sep 30, 202152.2%−13.8
Q2 FY2021Jun 30, 202163.5%+1.3
Q1 FY2021Mar 31, 202164.5%−0.5
Q4 FY2020Dec 31, 202064.1%−3.2
Q3 FY2020Sep 30, 202066.0%−0.2
Q2 FY2020Jun 30, 202062.2%−2.7
Q1 FY2020Mar 31, 202065.0%+0.4
Q4 FY2019Dec 31, 201967.3%+27.5
Q3 FY2019Sep 30, 201966.2%−0.5
Q2 FY2019Jun 30, 201964.9%−1.7
Q1 FY2019Mar 31, 201964.6%−3.6
Q4 FY2018Dec 31, 201839.7%−13.5
Q3 FY2018Sep 30, 201866.7%+9.3
Q2 FY2018Jun 30, 201866.6%+3.4
Q1 FY2018Mar 31, 201868.2%+0.7
Q4 FY2017Dec 31, 201753.2%−18.3
Q3 FY2017Sep 30, 201757.5%−11.7
Q2 FY2017Jun 30, 201763.2%–
Q1 FY2017Mar 31, 201767.5%–
Q4 FY2016Dec 31, 201671.6%–
Q3 FY2016Sep 30, 201669.2%–

More Xtant Medical figures

See a number that looks wrong?